Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Flamma Launches New cGMP Workshop | Contract Pharma

What are you searching for?

Sign in
Videos

Flamma Launches New cGMP Workshop

The $20M Dalian, China facility is also an R&D center

By: Betsy Louda

, Contract Pharma


Flamma, a contract manufacturing organization (CMO) that develops, manufactures, and commercializes small molecule active pharmaceutical ingredients (APIs) for the pharmaceutical industry, recently opened its new cGMP workshop and R&D Center in Dalian, China.

Dr. Gian Paolo Negrisoli, president and chief executive officer of Flamma said, “Flamma has been listening to its customers and their need to have a trusted supplier in China. Flamma is unique in our industry having the ability to provide customers manufacturing of APIs, RSMs, and advanced intermediates not only in Europe but also in China being led by one management team.”

This investment of $20M brings the total capacity of Flamma’s Chinese operations in Dalian to 200 m3 and brings the R&D group to the same campus for increased efficiency and productivity for their customers. By 2018, Flamma intends to spend $5M to expand its R&D capabilities with the addition of a new R&D building at its Chignolo d’Isola headquarters. By 2020, Flamma has plans to increase its production capacity by 40% with the addition of another cGMP workshop at its Chignolo d’Isola headquarters.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics